Universitätsklinikum Essen

Hospital


Location: Essen, Germany (DE) DE

ISNI: 0000000102627331

ROR: https://ror.org/02na8dn90

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Health literacy and information needs among German skin cancer patients in comparison to people without skin cancer: A survey (2023) Hoffmann J, Steeb T, Weber C, Doppler A, Schmitt J, Schadendorf D, Berking C, Meier F Journal article Serum KL-6 as a Candidate Predictor of Outcome in Patients with SARS-CoV-2 Pneumonia (2023) Kattner S, Sutharsan S, Berger MM, Limmer A, Jehn LB, Herbstreit F, Brenner T, et al. Journal article S3 guideline „actinic keratosis and cutaneous squamous cell carcinoma“ – update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention (2023) Leiter U, Heppt M, Steeb T, Alter M, Amaral T, Bauer A, Bechara FG, et al. Journal article Modulation of immune responses to liposomal vaccines by intrastructural help (2023) Damm D, Suleiman E, Wagner J, Klessing S, Pfister F, Elsayed H, Walkenfort B, et al. Journal article S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma"- update 2023, part 1: treatment of actinic keratosis, actinic cheilitis, cutaneous squamous cell carcinoma in situ (Bowen's disease), occupational disease and structures of care (2023) Heppt M, Leiter U, Steeb T, Alter M, Amaral T, Bauer A, Bechara FG, et al. Journal article S3-Leitlinie “Aktinische Keratose und Plattenepithelkarzinom der Haut“ – Update 2023, Teil 1: Therapie der aktinischen Keratose, Morbus Bowen, Cheilitis actinica, berufsbedingte Erkrankung und Versorgungsstrukturen (2023) Heppt M, Leiter U, Steeb T, Alter M, Amaral T, Bauer A, Bechara FG, et al. Journal article Preferences of German and Swiss melanoma patients for toxicities versus melanoma recurrence during adjuvant treatment (GERMELATOX-A-trial) (2023) Kähler KC, Hüning S, Nashan D, Meiss F, Rafei-Shamsabadi DA, Rissmann H, Colapietro C, et al. Journal article Palliativmedizin in onkologischen Spitzenzentren (2023) Gahr S, Berendt J, Tewes M Journal article Design and Implementation of an ETL-Process to Transfer Wound-Related Data into a Standardized Common Data Model (2023) Przysucha M, Hüsers J, Liberman D, Kersten O, Schlüter A, Fraas S, Busch D, et al. Book chapter / Article in edited volumes COMBI-r: A Prospective, Non-Interventional Study of Dabrafenib Plus Trametinib in Unselected Patients with Unresectable or Metastatic BRAF V600-Mutant Melanoma (2023) Berking C, Livingstone E, Debus D, Loquai C, Weichenthal M, Leiter U, Kiecker F, et al. Journal article